Two CodeX HL7 FHIR Accelerator use case teams are hosting monthly public calls to involve a broad community in early prototype development and pilot planning activities currently underway.
Computable Publishing LLC was pleased to sponsor the January 2022 HL7 Working Group Meeting, which aligns with our work towards creating software tools that support data exchange for scientific knowledge with HL7 Fast Healthcare Interoperability Resources (FHIR®). In fact, many already know that our CEO, Brian Alper, is the leader of the Evidence-Based Medicine on the FHIR project (EBMonFHIR) and the COVID-19 Knowledge Accelerator (COKA) initiative.
Background & Expansion
EBMonFHIR (sponsored by the CDS, BR&R and CQI HL7 work groups) previously created Citation, Evidence, EvidenceReport and Evidenceariable Resources. The project expansion to the COKA initiative now involves 12 active working group meetings per week. The combination of volunteer efforts from about 100 people in many countries along with software tools (provided gratis to COKA by Computable Publishing LLC) has produced impressive results to advance evidence-based medicine (EBM) and promote the HL7 FHIR standard to the EBM community.
To our HL7 International community,
The past two years have been challenging for all of us, and now the world is faced with the unfolding conflict in Eastern Europe.
We are sure that the events of the past 24 hours have left you, as they have us, saddened.
HL7 has a long-standing history of global participation, support and collaboration from across the world. We are proud to have such a united community dedicated to the advancement of interoperability and the betterment of healthcare across the world. Our mutual goals and passion have brought together individuals from diverse communities who have created strong bonds and friendships through their work within HL7.
On behalf of the HL7 US Realm Steering Committee (USRSC), we are pleased to share an update on last year's priorities and highlight our focus for 2022.
2021 Highlights
Visibility was a key theme of our work in 2021 and included supporting pilot work on a standards dashboard, tracking accelerator activity and promoting key ballots.
Before we dive into 2022, we want to highlight a few key points for all US Realm (USR) members.
- SMART v2: published new guidance on granular controls
- Bulk Data v2: published with numerous new features
- Errata release of Consolidated CDA (C-CDA): companion guide to support January 2022 ballot
- C-CDA Companion Guide: January 2022 ballot to add USCDI v2 guidance
- US FHIR Core - January 2022 ballot: to add USCDI v2 guidance
- Hosted reviews on HL7 Standards Dashboard Prototype
- C-CDA Web Publishing Trial Draft using FHIR Structure Definition
- Facilitated US@ project with ONC team
The CodeX HL7 FHIR Accelerator will host three public calls next week covering project milestones in the Radiation Therapy Treatment Data (RTTD), Risk Evaluation and Mitigation Strategies[i] (REMS) and Prior Authorization in Oncology use cases.
- Join the CodeX Prior Authorization in Oncology team on February 15 (3-4 ET) for an update on its radiation oncology pilot planning. Use case team members will discuss progress relative to breast and prostate cancer patient demographic and clinical data elements discovery and health data standards mapping (e.g., mCODE and Da Vinci Project implementation guides). Find call information here.
- Join the RTTD team on February 16 (11-12 ET) when they will share recent project achievements, including experience exchanging synthetic patient data using mCODE from a radiation oncology information test system to a FHIR server. Find call information here.
- Join the CodeX REMS team on February 17 (1-2 ET) to explore the value of an interoperable REMS ecosystem using FHIR and other health data standards, view details of the open source REMS on FHIR prototype under development and discuss CodeX membership details and benefits, including driving the REMS use case work forward. Find call information here.
The CodeX team believes the Minimal Common Oncology Data Elements (mCODE™) standard could be leveraged to achieve more equitable health outcomes for cancer patients from diverse populations. As part of our exploration, we are releasing a white paper, “Advancing Health Equity in Cancer Research, Care, and Surveillance,” available here and will host a companion webinar, "Leveraging Interoperability to Drive Health Equity in Cancer Care, Research and Surveillance." Please join us on January 27, 2022 at 1PM ET by registering here.
The Organization Welcomes Daniel Vreeman, D.P.T., Viet Nguyen, M.D., and Diego Kaminker
The Next Generation Standard Has Transformed Health Information Technology Across the Globe
HL7 Fast Healthcare Interoperability Resources (FHIR®), the widely adopted, open-source standard from the HL7 International community, celebrates 10 years of international development and implementation. With the ability to streamline the many variations in health information technology (HIT) systems and the capacity to accommodate modern technology, FHIR is at the forefront of healthcare interoperability. In keeping with HL7’s vision of a world where access to health data is readily available to everyone whenever and wherever it is needed, FHIR creates connections between different parts of the healthcare system to facilitate the secure, real-time exchange of data and, ultimately, improve patient care.
Since its inception, FHIR has fostered a collaborative culture. HL7 International Chief Executive Officer Charles Jaffe, M.D., Ph.D., recalls, "The development and adoption of FHIR was advanced by a remarkable and committed international community. The impact that FHIR has had on global healthcare was driven by an unprecedented level of collaboration that today continues to grow." Grahame Grieve, principal at Health Intersections, FHIR product director at HL7 and the inventor of FHIR, agrees. “Most people think about FHIR as a technical specification, but I look at it first of all as a community.”
